Cost-effectiveness of adjuvant intravaginal brachytherapy in high-intermediate risk endometrial carcinoma.

Brachytherapy（2018）

引用 5|浏览12

暂无评分

摘要

IVBT is cost-effective compared with observation after TH/BSO for HIR endometrial carcinoma by commonly accepted willingness-to-pay thresholds.

查看译文

关键词

Cost-effectiveness,Markov model,Endometrial carcinoma,High-intermediate risk,Intravaginal brachytherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要